Nanduri, S. A. et al. Epidemiology of invasive early-onset and late-onset group B Streptococcal disease in the United States, 2006 to 2015: multistate laboratory and population-based surveillance. JAMA Pediatr. 173, 224–233 (2019).
Article PubMed PubMed Central Google Scholar
Raabe, VN, Shane, AL. Group B Streptococcus (Streptococcus agalactiae). Microbiol Spectr. 2019;7. https://doi.org/10.1128/microbiolspec.GPP3-0007-2018
Madrid, L. et al. Infant group B streptococcal disease incidence and serotypes worldwide: systematic review and meta-analyses. Clin. Infect. Dis. 65, S160–S172 (2017). suppl_2.
Article PubMed PubMed Central Google Scholar
Phares, C. R. et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 299, 2056–2065 (2008).
Article CAS PubMed Google Scholar
Fernandez, M., Hickman, M. E. & Baker, C. J. Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob. Agents Chemother. 42, 1517–1519 (1998).
Article CAS PubMed PubMed Central Google Scholar
Castor, M. L. et al. Antibiotic resistance patterns in invasive group B streptococcal isolates. Infect. Dis. Obstet. Gynecol. 2008, 727505 (2008).
Francois Watkins, L. K. et al. Epidemiology of invasive group B streptococcal infections among nonpregnant adults in the United States, 2008–2016. JAMA Intern. Med. 179, 479–488 (2019).
Article PubMed PubMed Central Google Scholar
Cieslewicz, M. J. et al. Structural and genetic diversity of group B streptococcus capsular polysaccharides. Infect. Immun. 73, 3096–3103 (2005).
Article CAS PubMed PubMed Central Google Scholar
Edwards, M. S. & Baker, C. J. Group B streptococcal infections in elderly adults. Clin. Infect. Dis. 41, 839–847 (2005).
Borchardt, S. M. et al. Frequency of antimicrobial resistance among invasive and colonizing Group B streptococcal isolates. BMC Infect. Dis. 6, 57 (2006).
Article PubMed PubMed Central Google Scholar
McGee, L. et al. Multistate, population-based distributions of candidate vaccine targets, clonal complexes, and resistance features of invasive group B streptococci within the United States, 2015–2017. Clin. Infect. Dis. 72, 1004–1013 (2021).
Article CAS PubMed Google Scholar
Murdoch, D. R. & Reller, L. B. Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective. Antimicrob. Agents Chemother. 45, 3623–3624 (2001).
Article CAS PubMed PubMed Central Google Scholar
Flannery, D. D. et al. Antimicrobial susceptibility profiles among neonatal early-onset sepsis pathogens. Pediatr. Infect. Dis. J. 41, 263–271 (2022).
Guo, D. et al. Neonatal colonization of group B streptococcus in China: Prevalence, antimicrobial resistance, serotypes, and molecular characterization. Am. J. Infect. Control. 46, e19–e24 (2018).
Article CAS PubMed Google Scholar
Wu, B. et al. Phenotypic and genetic differences among group B Streptococcus recovered from neonates and pregnant women in Shenzhen, China: 8-year study. BMC Microbiol. 19, 185 (2019).
Article PubMed PubMed Central Google Scholar
Hays, C. et al. Changing epidemiology of group B streptococcus susceptibility to fluoroquinolones and aminoglycosides in France. Antimicrob. Agents Chemother. 60, 7424–7430 (2016).
Article CAS PubMed PubMed Central Google Scholar
Imperi, M. et al. Invasive neonatal GBS infections from an area-based surveillance study in Italy. Clin. Microbiol. Infect. 17, 1834–1839 (2011).
Article CAS PubMed Google Scholar
Kadanali, A., Altoparlak, U. & Kadanali, S. Maternal carriage and neonatal colonisation of group B streptococcus in eastern Turkey: prevalence, risk factors and antimicrobial resistance. Int. J. Clin. Pract. 59, 437–440 (2005).
Article CAS PubMed Google Scholar
Plainvert, C. et al. Multidrug-Resistant Hypervirulent Group B Streptococcus in Neonatal Invasive Infections, France, 2007–2019. Emerg. Infect. Dis. 26, 2721–2724 (2020).
Article CAS PubMed PubMed Central Google Scholar
Capanna, F. et al. Antibiotic resistance patterns among group B Streptococcus isolates: implications for antibiotic prophylaxis for early-onset neonatal sepsis. Swiss Med. Wkly 143, w13778 (2013).
Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States. U.S. Department of Health and Human Services; 2019.
Active Bacterial Core Surveillance; Centers for Disease Control and Prevention. Accessed 7 June 2022, https://www.cdc.gov/abcs/bact-facts-interactive-dashboard.html
Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Susceptibility Tests. 13th ed. Clinical Laboratory Standards Institute; 2018.
Cubria, M. B. et al. Population genomics reveals distinct temporal association with the emergence of ST1 serotype V Group B streptococcus and macrolide resistance in North America. Antimicrob. Agents Chemother. 66, e0071421 (2022).
Olesen SW, et al. The distribution of antibiotic use and its association with antibiotic resistance. Elife. 2018;7
Shenoy, E. S., Macy, E., Rowe, T. & Blumenthal, K. G. Evaluation and management of penicillin allergy: a review. JAMA 321, 188–199 (2019).
Richards VP, et al. Population gene introgression and high genome plasticity for the zoonotic pathogen Streptococcus agalactiae. Mol. Biol. Evol. 2019.
Da Cunha, V. et al. Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline. Nat. Commun. 5, 4544 (2014).
Teatero, S. et al. Clonal Complex 17 Group B Streptococcus strains causing invasive disease in neonates and adults originate from the same genetic pool. Sci. Rep. 6, 20047 (2016).
留言 (0)